ClinicalTrials.Veeva

Menu

A Clinical Data Collection Study of Verily Patch

V

Verily Life Sciences

Status

Terminated

Conditions

Febrile
Afebrile

Treatments

Device: Verily Patch

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This is a single center, prospective, non-randomized prospective observational data collection study of the Verily Patch. The Verily Patch is an investigational wearable, continuous temperature sensor which will be evaluated against reference oral and axillary temperature measurements to support development activities for the Verily Patch.

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • At least 18 years old
  • Able to read and speak English
  • Able to read and understand the Informed Consent Form
  • Willing to wear Verily Patch in the axillary region
  • Willing to comply with repeated self-measurement of oral and axillary temperatures and willing to record temperature readings
  • Have a working smartphone device and willing to use it for study activities
  • Willing to install study apps on their personal smartphone
  • Willing to comply with all study-related procedures

Exclusion criteria

  • Pregnant or breastfeeding during study participation
  • Have known allergies to medical grade adhesives
  • Have known cutaneous hypersensitivity
  • Have infection in both axilla
  • Have open injury or rash where the study device will be worn
  • Have a cardiac pacemaker or other implanted electronic medical device(s)
  • Have any additional condition or situation that, in the opinion of the investigator, makes the subject inappropriate for participation in the study

Trial design

22 participants in 2 patient groups

Febrile (n=50)
Description:
Febrile is defined as having sublingual temperatures of 37.5 °C or above. All subjects will wear the Verily Patch in the axillary region for up to 8 days. In addition, subjects will measure oral and axillary temperatures using a commercially available thermometer.
Treatment:
Device: Verily Patch
Afebrile (n=50)
Description:
Afebrile is defined as having sublingual temperatures of less than 37.5 °C. All subjects will wear the Verily Patch in the axillary region for up to 8 days. In addition, subjects will measure oral and axillary temperatures using a commercially available thermometer.
Treatment:
Device: Verily Patch

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems